Mylan Inc. today announced (in a press release Here) its plans to purchase the remaining interest in Matrix Laboratories Limited from minority shareholders pursuant to a voluntary delisting offer. Mylan, through a wholly-owned subsidiary, currently owns approximately 71.2% of Matrix and controls more than 76% of its voting rights. The impact of the transaction is anticipated to be accretive to Mylan's 2009 earnings.
Friday 27 March, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment